Nabla is the leading ambient AI assistant for practitioners. By assimilating vast medical databases, staying updated with the latest research, and understanding nuanced medical terminology, Nabla helps healthcare professionals in diagnosing illnesses, suggesting treatments, and providing comprehensive information, ultimately contributing to improved patient outcomes. Regular updates and enhancements augment its capabilities, ensuring practitioners have access to cutting-edge assistance.
Nabla has raised $24 million in a Series B funding round led by Cathay Innovation, with participation from ZEBOX Ventures — the corporate VC fund of CMA CGM. The new round has brought Nabla’s valuation to $180 million. In total, the company has raised $43 million till that moment.
Nabla, Paris, France, was founded in 2018 by Alexandre Lebrun, Delphine Groll, and Martin Raison. “This fundraise allows us to continue delivering on our vision to build the premier ambient AI assistant that will allow clinicians to experience the joy of practicing again,” said Alex Lebrun, co-founder and CEO of Nabla. “Clinical documentation is only the beginning for Nabla. Health systems are looking to leverage the AI opportunity to support their healthcare teams in many different aspects; we are getting ready to be there every step of the way.”
